Role of Branched-Chain Amino Acids in Mitigating Osteosarcopenia: An Experimental Study Using Ovariectomised Mice Models.

Geum-Hwa Lee, Hwa-Young Lee, Young-Jae Lim, Se-Woong Ko, Han-Jung Chae, Sun-Jung Yoon

Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, Republic of Korea.Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, Republic of Korea. · pubmed

Paper

Abstract

Osteosarcopenia, characterised by concurrent bone loss and muscle atrophy, presents a significant challenge in aging populations, particularly in postmenopausal women. The current therapeutic options potentially treat bone and muscle loss independently, highlighting the importance of an integrated approach. This study aimed to investigate the effects of branched-chain amino acid (BCAA) supplementation on muscle and bone health using ovariectomised (OVX) mice, a model for postmenopausal osteoporosis and sarcopenia.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper claims that branched-chain amino acid supplementation can improve muscle and bone health in ovariectomised mice. This research is relevant as it addresses the integrated approach to mitigating osteosarcopenia, a condition associated with aging, thereby contributing to the understanding of age-related muscle and bone loss.

Author of this paper? Send a correction.